phIL12 GET

N/A

Report date: 2024/07/19 20:00:07

Base Information

Drug NamephIL12 GET
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionInterleukin-12 receptor gene transference
TargetsInterleukin-12 receptor
Therapy Area/IndicationsCarcinoma, Basal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySlovenia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesInstitute Of Oncology Ljubljana
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Oncology Ljubljana
Inactive CompaniesN/A
Active IndicationsCarcinoma, Basal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A